beatandraise : SEC Filings Research with AI

beta

GILEAD SCIENCES, INC.

Exhibits

d10k.htm dex23.htm dex107.htm dex108.htm dex1090.htm dex211.htm dex231.htm dex311.htm dex312.htm dex321.htm gild-20101231.xml R19.xml R44.xml R80.xml R97.xml R35.xml R51.xml R29.xml R11.xml R10.xml R60.xml R30.xml R100.xml R54.xml R8.xml R36.xml R41.xml R79.xml R66.xml R72.xml R58.xml R22.xml R89.xml R74.xml R31.xml R45.xml R43.xml R73.xml R49.xml R53.xml R92.xml R18.xml R86.xml R98.xml R94.xml R32.xml R82.xml R67.xml R57.xml R12.xml R3.xml R14.xml R90.xml R48.xml R78.xml R15.xml R24.xml R69.xml R20.xml R4.xml R83.xml R77.xml R27.xml R101.xml R39.xml R75.xml R81.xml R96.xml R68.xml R70.xml R50.xml R33.xml R16.xml R28.xml R102.xml R76.xml R52.xml R62.xml R9.xml R6.xml R61.xml R88.xml R91.xml R85.xml R5.xml R23.xml defnref.xml R95.xml R84.xml R46.xml R21.xml R99.xml R87.xml R13.xml R34.xml R26.xml R93.xml R59.xml R64.xml R1.xml R2.xml R103.xml R37.xml R63.xml R56.xml Financial_Report.xls R55.xml R47.xml R38.xml R25.xml R7.xml R65.xml R40.xml R71.xml R42.xml R17.xml

Graphics

g121379g49a70.jpg

Notes Support

about terms

beatandraise.com

beta

GILEAD SCIENCES, INC.

Statements

Exhibits

Graphics

g121379g49a70.jpg

Notes Support

about terms

2.2.0.25falsefalse32003 - Disclosure - Quarterly Results Of Operations (Tables)truefalsefalse1falsefalseUSDfalsefalse1/1/2010 - 12/31/2010 USD ($) USD ($) / shares $Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0us-gaap_QuarterlyFinancialDataAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseQuarterly Results of Operations3false0gild_ScheduleOfQuarterlyResultsOfOperationsgildfalsenadurationSchedule Of Quarterly Results Of Operationsfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<div> <div class="MetaData"> <table border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td width="56%"> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="3%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">1st Quarter</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2nd Quarter</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">3rd Quarter</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">4th Quarter</td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> 2010 (1) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Total revenues</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,085,853</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,927,224</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,937,656</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,998,687</td> <td valign="bottom">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Gross profit on product sales</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,347,633</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,350,536</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,387,975</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,433,901</td> <td valign="bottom">  </td></tr> <tr><td valign="top"> Net income</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">852,094</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">709,127</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">702,163</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">626,365</td> <td valign="bottom">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net income attributable to Gilead</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">854,901</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">712,061</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">704,876</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">629,419</td> <td valign="bottom">  </td></tr> <tr><td valign="top"> Net income per share attributable to Gilead common stockholders—basic</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.95</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.81</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.85</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.78</td> <td valign="bottom">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net income per share attributable to Gilead common stockholders—diluted</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.92</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.79</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.83</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.76</td> <td valign="bottom">  </td></tr> <tr><td valign="top"> 2009</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total revenues</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,530,460</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,647,155</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,801,389</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,032,379</td> <td valign="bottom">  </td></tr> <tr><td valign="top"> Gross profit on product sales</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,118,166</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,185,333</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,239,255</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,330,999</td> <td valign="bottom">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net income</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">586,576</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">569,145</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">670,478</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">799,393</td> <td valign="bottom">  </td></tr> <tr><td valign="top"> Net income attributable to Gilead</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">589,112</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">571,398</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">673,033</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">802,212</td> <td valign="bottom">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net income per share attributable to Gilead common stockholders—basic</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.65</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.63</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.75</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.89</td> <td valign="bottom">  </td></tr> <tr><td valign="top"> Net income per share attributable to Gilead common stockholders—diluted</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.63</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.61</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.72</td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.87</td> <td valign="bottom">  </td></tr></table> <table style="border-collapse: collapse;" class="MetaData" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="4%" align="left">(1)</td> <td class="MetaData" valign="top" align="left">During 2010, we recorded $136.0 million of impairment charges in R&D expense, related to certain IPR&D assets acquired from CV Therapeutics. See Notes 5 and 9. </td></tr></table></div> </div>     1st Quarter      2nd Quarter      3rd Quarter      4th Quarter   201falsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringSchedule Of Quarterly Results Of OperationsNo authoritative reference available.falsefalseQuarterly Results of Operations12Quarterly Results Of Operations (Tables)UnKnownUnKnownUnKnownUnKnownfalsetrue